Sergey Bratukhin is a businessman, investor, and former corporate executive who has held leadership roles in major companies and later became widely known under the professional name Sergey Young. While many people recognize Sergey Young for his work in longevity investing and technology, fewer realize that public records identify him as Sergey Borisovich Bratukhin.
His career spans corporate governance, investment management, and venture capital, with experience ranging from board positions at one of the world’s largest mining companies to founding a global investment fund focused on extending healthy human lifespan.
Interest in Sergey Bratukhin has grown as more readers try to understand the connection between his corporate career in Russia and his current work as an international investor and longevity advocate. Public records, trademark filings, and professional profiles help connect these two identities, although many online articles explain only part of the story.
So, who is Sergey Bratukhin? Here’s everything to know about the businessman also known as Sergey Young.
Sergey Bratukhin Quick Facts
| Fact | Details |
|---|---|
| Full Name | Sergey Borisovich Bratukhin |
| Professional Name | Sergey Young |
| Profession | Businessman, Investor, Entrepreneur |
| Known For | Founder of Longevity Vision Fund |
| Nationality | Public records associate him with Russia and Cyprus |
| Education | D. Mendeleev University of Chemical Technology of Russia, Financial University, Warwick Business School |
| Former Corporate Role | Independent Director, MMC Norilsk Nickel |
| Previous Executive Position | President, Invest AG LLC |
| Industry | Venture Capital, Technology, Longevity Investing |
| Book | The Science and Technology of Growing Young |
| Current Focus | Longevity technologies and health innovation |
Who Is Sergey Bratukhin?
Sergey Bratukhin is a businessman whose career has evolved from corporate leadership and investment management into venture capital focused on healthcare innovation and longevity technologies. Although he is widely introduced today as Sergey Young, official trademark records publicly identify Sergey Young as the professional name associated with Sergey Bratukhin, helping explain why both names appear across different business and media sources.
His professional background combines experience in corporate governance, finance, and technology investing. Over the years, he has served on the boards of several companies while also building a reputation as an investor interested in emerging technologies that aim to improve human health and extend healthy lifespan.
Today, many international audiences know him through Longevity Vision Fund, his speaking engagements, and his writing about the future of healthcare rather than through his earlier corporate positions.
Early Life and Education
Compared with many public business figures, relatively little verified information has been published about Sergey Bratukhin’s childhood or family background. Public sources have not disclosed detailed information about his early years, parents, or upbringing, and those details should not be assumed.
His educational background, however, is better documented.
According to corporate biographies, Bratukhin graduated from the D. Mendeleev University of Chemical Technology of Russia in 1996. He later expanded his expertise by studying finance and business management, including programs at the Financial University and Warwick Business School.
This combination of scientific education and financial training helped shape the career path he would later follow. Rather than remaining in the chemical industry, he gradually moved into investment management, corporate strategy, and executive leadership.
His academic background also explains why his later work often combined technology, science, and investment rather than focusing on a single industry.
Building a Career in Investment and Corporate Leadership
Before becoming publicly associated with longevity investing, Sergey Bratukhin spent many years working in corporate finance and investment management.
One of his significant executive positions was serving as President of Invest AG LLC, where he worked within investment and financial management. Public corporate records also show leadership positions involving companies connected with transportation, finance, and industrial sectors.
His experience during this period centered on:
- Corporate governance
- Investment strategy
- Financial oversight
- Board management
- Executive leadership
Rather than building a public media profile, Bratukhin developed much of his career through board appointments and executive roles, making him better known within business and investment circles than among the general public.
This experience later became an important foundation for his transition into venture investing and technology-focused entrepreneurship.
Board Positions Across Major Companies
Public corporate records show that Sergey Bratukhin held director or board positions with several organizations during his career.
Among the companies publicly associated with him are:
- MMC Norilsk Nickel
- International Financial Club OJSC
- Dallesprom
- Amurskoye Parokhodstvo JSC
- Invest AG LLC
These appointments demonstrate experience across multiple industries, including natural resources, finance, transportation, and investment management.
Serving on company boards involves responsibilities that extend beyond daily management. Directors help oversee long-term strategy, governance standards, financial oversight, executive appointments, and shareholder interests. Bratukhin’s repeated appointments suggest he developed considerable expertise in these areas throughout his corporate career.
Sergey Bratukhin’s Role at Norilsk Nickel
One of the most significant positions in Sergey Bratukhin’s business career was his involvement with MMC Norilsk Nickel, one of the world’s largest producers of nickel and palladium.
Corporate disclosures identify him as an Independent Director and later as Chairman of the company’s Corporate Governance, Nomination and Remuneration Committee. He also participated in additional board committees responsible for areas such as strategy, budgeting, sustainable development, and corporate oversight.
These committee assignments indicate responsibilities beyond simply attending board meetings. They involved reviewing governance practices, executive compensation, board composition, strategic planning, and long-term organizational performance.
For investors and corporate observers, these governance roles represented an important stage in Bratukhin’s professional development. They strengthened his reputation as someone with experience in overseeing large international businesses operating in complex industries.
A Shift Toward Technology and Innovation
After years in traditional corporate leadership, Sergey Bratukhin gradually shifted his professional attention toward emerging technologies and venture investing.
This transition reflected broader changes occurring across global investment markets, where technology, artificial intelligence, biotechnology, and healthcare innovation increasingly attracted private capital.
Rather than focusing only on established corporations, Bratukhin became interested in businesses developing solutions for future scientific and medical challenges.
His investment philosophy increasingly emphasized innovation with long-term global impact, particularly companies working on improving health outcomes, extending healthy lifespan, and advancing biotechnology.
This shift marked an important turning point in his career, moving from corporate governance toward entrepreneurship and venture capital.
Why Sergey Bratukhin Is Also Known as Sergey Young
One question appears repeatedly in online searches: Is Sergey Bratukhin the same person as Sergey Young?
Publicly available records indicate that the answer is yes.
Trademark documentation filed for the name “Sergey Young” identifies Sergey Bratukhin as the individual associated with that name. Over time, he adopted Sergey Young as his public-facing professional identity, particularly for international business, media appearances, conference speaking engagements, book publishing, and investment activities.
As a result:
- Corporate filings and historical business records often use Sergey Bratukhin or Sergey Borisovich Bratukhin.
- More recent interviews, books, conferences, and investment activities generally use Sergey Young.
Understanding this distinction helps explain why different sources refer to the same businessman under different names. Many competitor articles mention only one identity, leaving readers uncertain about the connection between the two.
The Beginning of His Work in Longevity Investing
Adopting the Sergey Young brand also coincided with a major shift in the focus of his professional career.
Instead of concentrating primarily on corporate governance and investment management, he began investing in companies working on technologies designed to improve human health and extend healthy lifespan. His growing interest in preventive healthcare, biotechnology, artificial intelligence, and medical innovation eventually led to the creation of Longevity Vision Fund, which became one of the most visible parts of his international profile.
This move significantly expanded his public visibility. While his earlier career was largely known within corporate and financial circles, his work in longevity investing introduced him to a broader global audience through conferences, books, interviews, and collaborations focused on the future of healthcare and scientific innovation.
Longevity Vision Fund and His Growing International Profile
One of the defining chapters of Sergey Bratukhin’s career under the professional name Sergey Young has been his work in the longevity sector. In 2019, he founded Longevity Vision Fund, a venture capital fund focused on companies developing technologies that aim to improve health and extend healthy lifespan.
The fund invests in businesses working across several areas of healthcare innovation, including biotechnology, artificial intelligence, digital health, diagnostics, and age-related disease research. Rather than targeting traditional pharmaceutical investments alone, its strategy emphasizes technologies that could make preventive healthcare more accessible and improve quality of life as populations age.
This shift from corporate governance to venture investing reflects a broader change in his professional priorities. Instead of overseeing established companies, Bratukhin began supporting early-stage businesses working on scientific and medical breakthroughs with long-term global potential.
Promoting Longevity Through Public Speaking and Writing
Beyond investing, Sergey Bratukhin has become a public advocate for healthy aging and longevity science.
Using the name Sergey Young, he regularly speaks at international conferences focused on healthcare, technology, artificial intelligence, and innovation. His presentations often explore how emerging technologies could transform medicine over the coming decades and help people live healthier lives for longer.
He has also worked with organizations that promote innovation in health and scientific research. These public appearances have expanded his profile beyond the investment community, making him a recognizable figure in discussions about the future of healthcare and longevity.
In 2021, he published The Science and Technology of Growing Young, a book that examines advances in longevity research and practical approaches to healthy aging. The publication helped introduce his ideas to a broader audience and reinforced his position as both an investor and a public communicator on longevity-related topics.
Business Philosophy and Investment Focus
A consistent theme throughout Bratukhin’s career is his interest in long-term value creation.
His earlier corporate roles focused on governance, strategic oversight, and investment management. As his career evolved, those principles were applied to emerging industries rather than traditional sectors.
His investment interests now commonly include:
- Longevity technologies
- Biotechnology
- Artificial intelligence in healthcare
- Preventive medicine
- Digital health platforms
- Medical diagnostics
- Health-focused innovation
Rather than pursuing short-term market trends, his public statements and investment activities suggest a focus on technologies that could have lasting social and economic impact.
Public Image and Industry Reputation
Sergey Bratukhin maintains a relatively professional public profile compared with many high-profile entrepreneurs.
Most media coverage centers on his work as an investor, author, conference speaker, and advocate for longevity research rather than on his private life. Industry publications frequently reference his views on the future of medicine, healthcare innovation, and venture investing.
His earlier corporate experience also gives him a perspective that differs from many venture capital investors. Years spent serving on company boards and working in executive leadership positions provide experience in governance and long-term business strategy, which continues to shape his investment approach.
Personal Life
Despite his growing international profile, Sergey Bratukhin has kept his personal life largely private.
There is no publicly verified information confirming details about his spouse, children, parents, or broader family. Likewise, reliable public sources do not provide extensive information about his residence or personal lifestyle.
This level of privacy is consistent across most reputable business profiles. Any claims beyond publicly documented information should therefore be treated with caution unless supported by credible primary sources.
Estimated Net Worth
Sergey Bratukhin’s personal net worth has not been publicly confirmed.
Although he has held senior corporate positions and founded an investment fund focused on longevity technologies, no reliable source has published a verified estimate of his wealth. As a result, it would be inaccurate to assign a specific net worth figure.
Readers should be cautious of websites that publish unsupported estimates without citing credible financial disclosures or official records.
Career Timeline
| Year | Milestone |
|---|---|
| 1996 | Graduated from the D. Mendeleev University of Chemical Technology of Russia |
| 2000s | Built a career in investment management and corporate leadership |
| 2007–2017 | Held board positions with several companies, including Dallesprom and Amurskoye Parokhodstvo |
| 2013 | Publicly listed among candidates for the Board of Directors of MMC Norilsk Nickel |
| 2018 | Served as Chairman of Norilsk Nickel’s Corporate Governance, Nomination and Remuneration Committee |
| 2019 | Founded Longevity Vision Fund |
| 2021 | Published The Science and Technology of Growing Young |
| 2023 | Publicly associated with the launch of BOLD Longevity Growth Fund alongside Peter Diamandis |
| Present | Continues investing in healthcare innovation and longevity technologies under the name Sergey Young |
Why Sergey Bratukhin Continues to Attract Public Interest
Search interest in Sergey Bratukhin has increased for two main reasons.
The first is the connection between Sergey Bratukhin and Sergey Young, which is not always clearly explained in online biographies. Readers often encounter both names in different contexts and want to know whether they refer to the same individual.
The second is his growing role in the longevity industry. As investment in biotechnology, artificial intelligence, and healthy aging continues to expand, his work with Longevity Vision Fund has attracted attention from investors, entrepreneurs, researchers, and technology enthusiasts.
Together, these factors have made him a notable figure at the intersection of business, venture capital, and healthcare innovation.
Conclusion
Sergey Bratukhin has built a career that spans corporate governance, investment management, and venture capital. While his earlier professional achievements were primarily linked to executive and board positions, he is now widely recognized as Sergey Young, the founder of Longevity Vision Fund and a prominent advocate for longevity innovation.
His career illustrates a transition from traditional corporate leadership to investing in technologies that address long-term healthcare challenges. Although many aspects of his private life remain undisclosed, his professional contributions are well documented through corporate records, public speaking, authorship, and his ongoing work in the global longevity sector.
Frequently Asked Questions
Who is Sergey Bratukhin?
Sergey Bratukhin is a businessman, investor, and former corporate executive who is also publicly known by the professional name Sergey Young. He is the founder of Longevity Vision Fund and previously held leadership roles in several companies, including MMC Norilsk Nickel.
Is Sergey Bratukhin the same person as Sergey Young?
Yes. Public trademark records identify Sergey Young as the professional name associated with Sergey Bratukhin, explaining why both names appear in business records and media coverage.
What is Sergey Bratukhin known for?
He is known for his earlier corporate leadership roles, his work in investment management, and his current focus on longevity investing through Longevity Vision Fund.
What book has Sergey Bratukhin written?
Under the name Sergey Young, he is the author of The Science and Technology of Growing Young, published in 2021.
What companies has Sergey Bratukhin worked with?
Public records associate him with organizations including MMC Norilsk Nickel, Invest AG LLC, International Financial Club OJSC, Dallesprom, and Amurskoye Parokhodstvo.
What is Sergey Bratukhin’s net worth?
There is no publicly verified estimate of Sergey Bratukhin’s net worth. Reputable sources have not disclosed a confirmed figure.
